Fat loss, glucose control, mitochondrial metabolism, and metabolic optimization
Showing all 5 results
GLP-2/T is a dual GIP and GLP-1 receptor agonist that mimics the body’s natural incretin signaling to enhance insulin sensitivity, reduce appetite, and improve adipose metabolism. Its dual-agonist mechanism delivers superior metabolic regulation compared to single-receptor incretin therapies. Mechanism of Action: GLP-1 receptor activation → Enhances glucose-dependent insulin secretion, slows gastric emptying, and promotes central…
GLP-2/T is a dual GIP and GLP-1 receptor agonist that mimics the body’s natural incretin signaling to enhance insulin sensitivity, reduce appetite, and improve adipose metabolism. Its dual-agonist mechanism delivers superior metabolic regulation compared to single-receptor incretin therapies. Mechanism of Action: GLP-1 receptor activation → Enhances glucose-dependent insulin secretion, slows gastric emptying, and promotes central…
GLP-3/R is a next-generation triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. By activating three distinct hormonal pathways, GLP-3/R represents the most advanced metabolic peptide in current research—delivering unmatched appetite suppression, energy expenditure, and fat oxidation compared to single- or dual-agonist compounds. Mechanism of Action: GLP-1 agonism → Enhances glucose-dependent insulin release, reduces gastric…
GLP-3/R is a next-generation triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. By activating three distinct hormonal pathways, GLP-3/R represents the most advanced metabolic peptide in current research—delivering unmatched appetite suppression, energy expenditure, and fat oxidation compared to single- or dual-agonist compounds. Mechanism of Action: GLP-1 agonism → Enhances glucose-dependent insulin release, reduces gastric…
GLP-3/R is a next-generation triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. By activating three distinct hormonal pathways, GLP-3/R represents the most advanced metabolic peptide in current research—delivering unmatched appetite suppression, energy expenditure, and fat oxidation compared to single- or dual-agonist compounds. Mechanism of Action: GLP-1 agonism → Enhances glucose-dependent insulin release, reduces gastric…
Notifications
